Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eagle Pharmaceuticals (NQ: EGRX )

45.78 USD +0.10 (+0.22%)
Official Closing Price Updated: 4:02 PM EST, Feb 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Eagle Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Financial Results and Pipeline Review on March 2, 2021
Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its 2020 fourth quarter and full year financial results on Tuesday, March 2, 2021,... 
From Business Wire News Releases
FDA Rejects Eagle Pharma's Vasopressin Application
The FDA hasissued a complete response letter(CRL) forEagle Pharmaceuticals Inc's(NASDAQ:EGRX) ... 
Tags Top Stories Small Cap FDA
From Benzinga
Eagle Pharmaceuticals Receives Additional FDA Questions Regarding Vasopressin; Court Date Set for July 7, 2021 in Vasopressin Trial
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that the U.S. Food and Drug Administration (“FDA”) has issued a complete response letter (“CRL”) for its... 
From Business Wire News Releases
Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that, on January 29, 2021, the United States District Court for the District of Delaware (the “Court”) postponed... 
From Business Wire News Releases
Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed from January 11, 2021 to February 1, 2021 to Protect Against COVID-19 Concerns
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that, on January 8, 2021, the United States District Court for the District of Delaware postponed the January 11,... 
From Business Wire News Releases
Eagle Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at the 39th... 
From Business Wire News Releases
Eagle Pharmaceuticals’ Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that the Company’s pre-recorded presentation at the Piper Sandler 32nd Annual Virtual Healthcare Conference is now... 
From Business Wire News Releases
EGRX Makes Notable Cross Below Critical Moving Average
In trading on Friday, shares of Eagle Pharmaceuticals, Inc. (EGRX) crossed below their 200 day moving average of $46.50, changing hands as low as $45.85 per share.. 
Tags Stocks
From Market News Video
WaterMill Asset Management Sends Letter to Ziopharm Oncology Shareholders
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of... 
From Business Wire News Releases
Eagle Pharmaceuticals: Q3 Earnings Insights
Shares of Eagle Pharmaceuticals (NASDAQ:EGRX) remained unaffected after the company reported Q3 results. Quarterly ... 
Tags Market News Earnings Benzinga
From Benzinga
Earnings Scheduled For November 2, 2020
Companies Reporting Before The Bell • Itron (NASDAQ:ITRI) is likely to report quarterly earnings at $0.25 per share on ... 
Tags Market News OSPN OTTR
From Benzinga
Eagle Pharmaceuticals Reports Third Quarter 2020 Results
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced financial results for the three and nine months ended September 30, 2020. 
From Business Wire News Releases
Eagle Pharmaceuticals Strengthens Management Team to Prepare for Future Growth
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced four additions to its clinical, formulations and commercialization leadership teams: Judith (“Judi”) Ng-Cashin,... 
From Business Wire News Releases
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ... 
Tags FLXN AXNX AVNS
From Benzinga
Eagle Pharmaceuticals to Discuss Third Quarter 2020 Financial Results on November 2, 2020
Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its 2020 third quarter financial results on Monday, November 2, 2020, before the... 
From Business Wire News Releases
Eagle Pharmaceuticals Commences $25 Million Accelerated Share Repurchase as Part of Existing $160 Million Share Repurchase Program
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that its Board of Directors has approved a $25 million accelerated share repurchase (“ASR”) transaction with... 
From Business Wire News Releases
Eagle Pharmaceuticals’ Japanese Licensing Partner, SymBio, Receives Approval of TREAKISYM Ready-To-Dilute (“RTD”) Formulation, with Launch Expected in January 2021
Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) today announced that its marketing partner, SymBio Pharmaceuticals Limited (“SymBio”), has received regulatory approval for... 
From Business Wire News Releases
Eagle Pharmaceuticals to Present at Upcoming September 2020 Healthcare Conferences
Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at two upcoming... 
From Business Wire News Releases
Eagle Pharmaceuticals Announces Publication of Preclinical Study of Intranasal Dantrolene in Journal of Alzheimer’s Disease
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that preclinical research on dantrolene sodium was published today in the peer-reviewed Journal of Alzheimer’s... 
From Business Wire News Releases
The Week Ahead In Biotech: Spotlight On Gilead, BioMarin FDA Decisions, Biotech IPOs
Biotech stocks came under pressure in the week ended Aug. 14 amid mixed earnings news flow from the sector. FDA decisions scheduled for ... 
Tags Health Care News EGRX
From Benzinga
Eagle Pharmaceuticals Inc (EGRX) Q2 2020 Earnings Call Transcript
EGRX earnings call for the period ending June 30, 2020. 
Tags Market News EGRX
From Motley Fool
Recap: Eagle Pharmaceuticals Q2 Earnings
Shares of Eagle Pharmaceuticals (NASDAQ:EGRX) were flat in pre-market trading after the company reported Q2 results. Quarterly ... 
Tags Benzinga Earnings Market News
From Benzinga
Eagle Pharmaceuticals Reports Second Quarter 2020 Results
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced financial results for the three and six months ended June 30, 2020. 
From Business Wire News Releases
Earnings Scheduled For August 10, 2020
Companies Reporting Before The Bell • Acacia Research Inc. (NASDAQ:ACTG) is expected to report quarterly loss at $0.02 per share ... 
Tags PXLW STRS MAR
From Benzinga
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive ... 
Tags ACRX Penny Stocks RETA
From Benzinga
Eagle Pharmaceuticals to Discuss Second Quarter 2020 Financial Results on August 10, 2020
Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its 2020 second quarter financial results on Monday, August 10, 2020, before the... 
From Business Wire News Releases
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical ... 
Tags DVAX REGN OXFD
From Benzinga
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
July turned out to be a mixed month for FDA approvals. Endo International PLC's (NASDAQ: ENDP) cellulite treatment, Osmotica ... 
Tags RHHBY MESO XBI
From Benzinga
CMS Establishes Unique J-Code for Eagle Pharmaceuticals’ PEMFEXY™ (Pemetrexed for Injection)
Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) today announced that the Centers for Medicare & Medicaid Services (CMS) has established a unique, product-specific billing code for... 
From Business Wire News Releases
The Week Ahead In Biotech: Endo, Eagle Pharma FDA Decisions, ObsEva Late-Stage Readouts In Focus
Biotech stocks rebounded in the holiday-shortened week ending July 2as investors reacted to pending clinical trial readouts and ... 
Tags Market News LTRN PFE
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.